Fidelity Covington Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & CoLLY | 13.35% | $438.89M | 382,033 |
| Johnson & JohnsonJNJ | 8.93% | $293.72M | 1,145,771 |
| AbbVie IncABBV | 6.42% | $211.14M | 841,398 |
| UnitedHealth Group IncUNH | 5.44% | $178.93M | 431,779 |
| Merck & Co IncMRK | 4.66% | $153.13M | 1,176,113 |
| Thermo Fisher Scientific IncTMO | 3.09% | $101.53M | 176,781 |
| Amgen IncAMGN | 3.00% | $98.77M | 256,433 |
| Abbott LaboratoriesABT | 2.66% | $87.57M | 828,501 |
| Gilead Sciences IncGILD | 2.34% | $76.88M | 590,446 |
| Pfizer IncPFE | 2.06% | $67.68M | 2,705,939 |
| Bristol-Myers Squibb CoBMY | 1.93% | $63.43M | 971,248 |
| CVS Health CorpCVS | 1.92% | $63.20M | 605,189 |
| Intuitive Surgical IncISRG | 1.82% | $59.70M | 168,952 |
| Danaher CorpDHR | 1.80% | $59.08M | 302,986 |
| Vertex Pharmaceuticals IncVRTX | 1.76% | $57.73M | 120,999 |
| Stryker CorpSYK | 1.62% | $53.40M | 163,965 |
| Medtronic PLC | 1.59% | $52.15M | 610,739 |
| McKesson CorpMCK | 1.52% | $49.89M | 58,268 |
| Elevance Health IncELV | 1.19% | $39.27M | 104,494 |
| Regeneron Pharmaceuticals IncREGN | 1.15% | $37.69M | 49,425 |
| Cigna Group/TheCI | 1.06% | $35.00M | 125,422 |
| Boston Scientific CorpBSX | 1.00% | $33.04M | 706,971 |
| HCA Healthcare IncHCA | 0.91% | $29.97M | 74,445 |
| Cencora IncCOR | 0.83% | $27.37M | 87,910 |
| Cardinal Health IncCAH | 0.78% | $25.75M | 111,939 |
| Edwards Lifesciences CorpEW | 0.72% | $23.61M | 274,258 |
| Becton Dickinson & CoBDX | 0.68% | $22.45M | 135,578 |
| IDEXX Laboratories IncIDXX | 0.64% | $21.12M | 37,781 |
| Humana IncHUM | 0.63% | $20.78M | 57,108 |
| IQVIA Holdings IncIQV | 0.58% | $18.97M | 80,727 |
| Agilent Technologies IncA | 0.57% | $18.60M | 134,433 |
| Waters CorpWAT | 0.54% | $17.65M | 46,780 |
| Natera IncNTRA | 0.52% | $17.15M | 64,051 |
| Zoetis IncZTS | 0.47% | $15.46M | 200,057 |
| Dexcom IncDXCM | 0.46% | $15.28M | 183,141 |
| GE HealthCare Technologies IncGEHC | 0.45% | $14.77M | 217,112 |
| ResMed IncRMD | 0.44% | $14.62M | 69,318 |
| Centene CorpCNC | 0.44% | $14.56M | 233,934 |
| Illumina IncILMN | 0.44% | $14.55M | 70,943 |
| Revolution Medicines IncRVMD | 0.44% | $14.43M | 76,953 |
| Veeva Systems IncVEEV | 0.43% | $14.25M | 69,951 |
| Biogen IncBIIB | 0.43% | $14.17M | 69,831 |
| Mettler-Toledo International IncMTD | 0.42% | $13.71M | 9,678 |
| Alnylam Pharmaceuticals IncALNY | 0.39% | $12.97M | 63,090 |
| Quest Diagnostics IncDGX | 0.37% | $12.19M | 52,313 |
| Labcorp Holdings IncLH | 0.37% | $12.13M | 39,235 |
| West Pharmaceutical Services IncWST | 0.36% | $11.68M | 34,263 |
| Royalty Pharma PLC | 0.35% | $11.43M | 195,701 |
| STERIS PLC | 0.32% | $10.63M | 46,559 |
| Tenet Healthcare CorpTHC | 0.32% | $10.56M | 41,449 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.